Sees Q3: Revenue from pharma tests and services, and all other customers to be in the range of $11.0 to $13.0 million. Revenue from population sequencing and enterprise sales of approximately $1.0 million
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL: